We thank Blueprint Medicines for their sponsorship of this blog post to help us share information for people managing systemic mastocytosis (SM). This is a sponsored post and is not an endorsement of any company or its products, nor is it a guarantee of any product’s safety. The funding we received for this advertisement helps support our free asthma and allergy programs.
Systemic mastocytosis (SM) affects nearly 32,000 people in the United States. People with SM have too many abnormal mast cells that cause a wide range of symptoms, including rashes, shortness of breath, and/or anaphylaxis. SM symptoms can look like asthma and allergy symptoms.
Interested in learning more? Blueprint Medicines is offering an informational program about SM this fall. During each virtual program, you’ll hear from a doctor and a person who will share their experience managing SM. You’ll also be able to participate in a live Q&A session. With four programs to choose from, you can pick the date and time that works best for you.
About Blueprint Medicines
Blueprint Medicines is a biopharmaceutical company studying oncology, hematology, and rare diseases. These programs do not provide medical advice. Remember to always consult with your doctor about your own health.